Adrenergic beta-3 Receptor Agonists
"Adrenergic beta-3 Receptor Agonists" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Compounds that bind to and activate ADRENERGIC BETA-3 RECEPTORS.
| Descriptor ID |
D058667
|
| MeSH Number(s) |
D27.505.519.625.050.100.200.300 D27.505.696.577.050.100.200.300
|
| Concept/Terms |
Adrenergic beta-3 Receptor Agonists- Adrenergic beta-3 Receptor Agonists
- Adrenergic beta 3 Receptor Agonists
- Adrenergic beta3-Agonists
- Adrenergic beta3 Agonists
- beta3-Agonists, Adrenergic
- Adrenergic beta-3 Agonists
- Adrenergic beta 3 Agonists
- Agonists, Adrenergic beta-3
- beta-3 Agonists, Adrenergic
- Adrenergic beta-3 Receptor Agonist
- Adrenergic beta 3 Receptor Agonist
|
Below are MeSH descriptors whose meaning is more general than "Adrenergic beta-3 Receptor Agonists".
Below are MeSH descriptors whose meaning is more specific than "Adrenergic beta-3 Receptor Agonists".
This graph shows the total number of publications written about "Adrenergic beta-3 Receptor Agonists" by people in this website by year, and whether "Adrenergic beta-3 Receptor Agonists" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2018 | 1 | 1 | 2 |
To return to the timeline, click here.
Below are the most recent publications written about "Adrenergic beta-3 Receptor Agonists" by people in Profiles.
-
Rationale and design of a multicentre, randomized, placebo-controlled trial of mirabegron, a Beta3-adrenergic receptor agonist on left ventricular mass and diastolic function in patients with structural heart disease Beta3-left ventricular hypertrophy (Beta3-LVH). ESC Heart Fail. 2018 10; 5(5):830-841.
-
Trends in the use of older overactive bladder agents and uptake of fesoterodine and mirabegron in Canada. Neurourol Urodyn. 2018 06; 37(5):1693-1700.